Alphafold

Google has shut down its Nobel-prize winning AlphaFold project, with DeepMind's award-winning AlphaFold team now dissolved as the company shifts focus to Gemini.

Google DeepMind has dismantled the Nobel-winning AlphaFold team as part of a strategic shift. The move redirects focus toward a broader race to develop AI systems for scientific discovery.

A drug metabolism AI competition highlights that larger AI models may not always be superior, focusing on solving drug development challenges like predicting activation of the pregnane X receptor (PXR), which regulates an enzyme breaking down 50% of marketed drugs. Reliable AI prediction of PXR activation could address issues like rapid drug elimination and drug–drug interactions.

Google DeepMind CEO Demis Hassabis stated the company remains competitive in attracting AI talent despite recent departures of top researchers like Noam Shazeer and John Jumper. He emphasized Google's structural advantages, including data, hardware, and computing power, to retain researchers in the fiercely competitive AI job market.

Google is losing top AI talent to competitors like OpenAI and Anthropic as high-profile researchers Noam Shazeer, John Jumper, and Andrej Karpathy leave for new roles. The departures have caused Google's stock to decline and highlight intensified competition in the AI industry.

John Jumper, a Nobel Prize winner for his work on AlphaFold with Demis Hassabis, is leaving Google DeepMind to join Anthropic. Jumper's AlphaFold technology revolutionized protein structure prediction, enabling significant advancements in medical and biological research.

Chemist Tim Cernak transitioned from pharmaceuticals to conservation, using AI and protein-modeling software like AlphaFold to design targeted treatments for animals and ecosystems. He works with species like Gila monsters, bald eagles, and loggerhead sea turtles, advocating for 'conservation chemistry' to address ecological health.

A new open-source AI tool called ESMFold2 has significantly expanded the known protein universe, building on the efforts of Alphafold. The tool generates a vast protein-folding atlas, enhancing scientific understanding of proteins.

Vertu, a luxury phone maker, has reintroduced the AlphaFold folding phone with AI-powered Hermes Agent software, targeting wealthy consumers. The device features decent specifications and aims to reestablish the brand in the premium smartphone market.

A new open-source AI model called ESMFold2 has generated an atlas predicting the shapes of 1 billion proteins, significantly expanding the known protein universe. This advancement surpasses previous tools like AlphaFold in scale and accessibility.

Google I/O keynote highlighted tension between two AI approaches for science: specialized tools like WeatherNext for specific problems versus autonomous AI agents that could conduct research independently. While Google continues developing specialized AI tools like AlphaFold that are widely used by researchers, the company is moving toward agentic LLM-based systems that could eventually perform cutting-edge science without human involvement.

Demis Hassabis, CEO of Google DeepMind, is a key figure in the Musk v. Altman trial, having founded DeepMind and sold it to Google for $400-650 million. He has led many AI research breakthroughs, including AlphaFold. Hassabis' work has been influential in Google's AI lab.